en 
Medical device company Merit Medical Systems (NASDAQ:MMSI) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.4% year on year to $355.2 million. The company expects the full year’s revenue to be around $1.48 billion, close to analysts’ estimates. Its non-GAAP profit of $0.93 per share was 12.2% above analysts’ consensus estimates.
Database as a service company Couchbase (NASDAQ: BASE) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 9.6% year on year to $54.92 million. On the other hand, next quarter’s revenue guidance of $55.5 million was less impressive, coming in 1.9% below analysts’ estimates. Its non-GAAP loss of $0 per share was significantly above analysts’ consensus estimates.
Restaurant software company (NYSE:OLO) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 20.7% year on year to $76.07 million. Guidance for next quarter’s revenue was better than expected at $77.45 million at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $0.06 per share was in line with analysts’ consensus estimates.
The ultimate “Trump trade” has run into trouble.
Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 10% year on year to $361.5 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.51 billion at the midpoint. Its GAAP profit of $0.75 per share was 5.7% below analysts’ consensus estimates.
Discount grocery store chain Grocery Outlet (NASDAQ:GO) announced better-than-expected revenue in Q4 CY2024, with sales up 10.9% year on year to $1.10 billion. The company expects the full year’s revenue to be around $4.75 billion, close to analysts’ estimates. Its non-GAAP profit of $0.15 per share was 10.3% below analysts’ consensus estimates.
Social media management software company Sprout (NASDAQ:SPT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 14.4% year on year to $107.1 million. On the other hand, next quarter’s revenue guidance of $107.6 million was less impressive, coming in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.19 per share was 25.4% above analysts’ consensus estimates.
Advertising and marketing company Zeta Global (NYSE:ZETA) announced better-than-expected revenue in Q4 CY2024, with sales up 49.6% year on year to $314.7 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $254 million was less impressive, coming in 1.2% below expectations. Its GAAP profit of $0.06 per share was $0.02 above analysts’ consensus estimates.
Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 3.4% year on year to $213.6 million. The company’s full-year revenue guidance of $960 million at the midpoint came in 2.7% above analysts’ estimates. Its non-GAAP profit of $0.64 per share was 30.6% above analysts’ consensus estimates.
Ukraine and the U.S. have reached an agreement on a framework for a broad economic deal that would include access to Ukraine's rare earth minerals, three senior Ukrainian officials said Tuesday. One of them said that Kyiv hopes that signing the agreement will ensure the continued flow of U.S. military support that Ukraine urgently needs. The agreement could be signed as early as Friday and plans are being drawn up for Ukrainian President Volodymyr Zelenskyy to travel to Washington to meet President Donald Trump, according to one of the Ukrainian officials.
Chinese (Traditional)
French
Italian
Spanish
Japanese
Korean